Menu
ENTOD meets Drug Controller General of India, issues clarificatio
Mumbai-based ENTOD Pharmaceuticals met with the Drug Controller General of India (DCGI) earlier this week to address...
Entod pharma to move court against DCGI's order
The drug regulator suspended permission, citing the company's failure to respond to the queries on the product for...
Drug regulator suspends product PresVu over unauthorised promotio
The Drugs Controller General of India (DCGI) on Wednesday suspended the product PresVu produced by Entod...
Entod Pharmaceuticals PresVu eye drops
The ENTOD Pharmaceuticals claiming PresVU eye drops approved by DCGI offering spectacular treatment for...
New initiative by the DCGI to boost ease of doing business
In a recent public notice, the Drug Controller General of India (DCGI) announced a new initiative aimed at enhancing...
DCGI bans charges, except supply, processing costs on blood units
The Drugs Controller General of India (DCGI) has waived all charges except processing costs on blood units.
Glenmark is first to launch Biosimilar of Liraglutide in India
Mumbai (Maharashtra) [India], January 3: Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global...
NHRC sends notice to Delhi Chief Secy, DCGI over epilepsy drug
The National Human Rights Commission (NHRC) sent notices to the Delhi Chief Secretary, Drugs Controller General of...
Mandaviya directs regulator to act against spurious drugs maker
Union Health Minister Mansukh Mandaviya has directed the Drugs Controller General of India (DCGI) to take stringent...
Intas launches DCGI-approved Tofacitinib Topical (JAKi)
Ahmedabad (Gujarat) [India], June 29: Intas Pharmaceuticals Ltd., one of India's leading pharmaceutical companies...
Booster vaccine for Omicron variant gets emergency use approval
The mRNA-based booster vaccine GEMCOVAC®-OM, developed to provide immunity against the Omicron variant of...
AstraZeneca receives nod to import breast cancer treating drug
AstraZeneca Pharma India Ltd., a science-led biopharmaceutical company, on Wednesday announced that it has...
Home
About Us
Our Products
Advertise
Contact Us
Terms & Condition
Privacy Policy
Copyright © aninews.in | All Rights Reserved.
Copyright © aninews.in | All Rights Reserved.